Abstract
6072Background: About 20% of R/M HNSCC pts have an objective response with anti-PD1/PD-L1 inhibitors after platinum failure. Some pts, however, experience a rapid flare-up during treatment. We eval...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
